Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 355 publications
Evidence of genetic susceptibility to immune-related dermatitis in patients with melanoma treated with immune checkpoint inhibitors.
Journal: Melanoma research
Published: May 19, 2026
Immune Checkpoint Inhibitor Esophagitis: Clinical and Endoscopic Presentation, Treatment Outcomes, and Complications.
Journal: Clinical and translational gastroenterology
Published: December 09, 2025
A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 27, 2025
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanoma.
Journal: Melanoma research
Published: November 26, 2025
Brief Communication: Personalized Circulating Tumor DNA as a Predictor of Pathologic Response in Neoadjuvant Treatment of Resectable Melanoma.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: September 26, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.
Journal: JCO precision oncology
Published: September 04, 2025
Phase II Trial of Cabozantinib in Combination with Nivolumab for Advanced Extrapancreatic Neuroendocrine Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 01, 2025
Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stress.
Journal: Cancer letters
Published: May 12, 2025
Same-Slide Spatial Multiomics Integration with IN-DEPTH Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.
Journal: Cancer discovery
Published: May 05, 2025
Rationale and feasibility of a rapid integral biomarker program that informs immune-oncology clinical trials: the ADVISE trial.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2025
Last Updated: 09/26/2026